News

A support group developed by a hospital in New York has shown that patients with rheumatoid arthritis can see their condition improve by not only addressing the physical symptoms but the psychological issues as well.

The firm Cadila is launching its biosimilar Exemptia in India for about 1/5 the price tag of Abbot's Humira. Most biosimilars to date are sold at roughly two-thirds the cost of the FDA-approved versions.

(ACR2014) Another Rheumatology Network Editorial Board member weighs in: Christopher Collins MD saw reason for great encouragement in a report about an interferon-α blocker for systemic lupus erythematosus.

As electronic health records become more or less mandatory, the question moves from how widely they are adopted by practices across the country to whether the new versions are more effective than the old pen-and-paper way of doing business.

Thymoma is rare and most known for its presence in 15% of patients who have myasthenia gravis. Thymoma tumors can be quite large. Surgery is the mainstay of treatment for thymoma, but when thymoma recurs (as it does in 10% to 30% of patients), the best course of action is often unclear.

Researchers compared the effectiveness of biologics approved in Europe for the treatment of plaque psoriasis based on their performance as measured by primary endpoints in clinical trials.

(ACR2014) A team from Rush University says their new 10-point instrument developed should be useful to track lupus disease status for trials and in the clinic.

Intra-articular injection of two widely used plant and mineral extract-based formulations provide long-lasting pain relief in patients with moderate to severe pain from knee osteoarthritis, according to the first-ever double-blind trial of the treatments.

Women using intrauterine devices with a family history of rheumatoid arthritis are at greater risk for the condition.

(ACR2014) Early comparisons of patients with rheumatic disease who use marijuana with those who don't show that the practice is not associated with better pain relief. But it is associated with some "sobering" consequences.

Doctors treating a patient for a lupus flare presenting as a fever were puzzled when her body temperature suddenly plunged. After solving the problem, they learned that it is rare but not unique -- and may be somewhat predictable.

This 14-year-old girl not only has lupus; she has also been diagnosed with arthritis, a vasculitic rash, and myositis. Can you guess what's actually going on here?

Autoimmune hepatitis (AIH) represents a complex and heterogenous disease entity, with an increasing incidence for both genders and worldwide.

White blood cells may be the cause of rheumatoid arthritis, according to a study from Northwestern Medicine.

Statin use by patients with muscle damage may induce neoantigens, leading to polymyalgia rheumatica and giant cell arteritis.

The authors reviews several challenging cases illustrating the utility of the anion gap in the evaluation of an acidotic patient.

New rheumatology-focused electronic health record systems make recording patient assessments easier. However, there's still plenty of room for improvement

Carpal tunnel syndrome pain is effectively reduced using topical menthol gel, according to a study from Denmark.

Pain and depression, but not disability, stem from sleep disturbances in patients with osteoarthritis, suggests a study published in Arthritis Care & Research.

The rare diseases that prevent immunoglobulin molecules from forming properly can present with symptoms typical of rheumatic disease: rashes, joint swelling, and stiffness.

Nausea and vomiting are the first symptoms of lupus in these three case studies. The consequences of misdiagnosis can be life-threatening.

Recent approvals and ongoing research have expanded the number of treatment options available to pediatricians and their patients.

Risks for venous and pulmonary thromboembolism are increased dramatically in patients with giant cell arteritis, especially in the first year after diagnosis.

Already discontinued for rheumatoid arthritis, the candidate drug tabalumab will no longer be tested for lupus either. Observers are taking a positive view of the situation.

A drug designed to treat patients with rheumatoid arthritis could also make them more susceptible to shingles, according to the results of a recent study.

Symptoms of neuropathy are present in patients with knee osteoarthritis, according to research from the University of Nottingham in the United Kingdom.

Trials of tabalumab showed "insufficient efficacy."

People who have rheumatoid or psoriatic arthritis or lupus are at increased risk for shingles. Studies suggest that treatment for the rheumatic condition may be a factor in certain circumstances.

Polymyositis and dermatomyositis appear to be triggered by the response of certain receptors to danger signals from damaged cells. This offers a new avenue for treatments now in testing.